NEW YORK, Sept 21 – Nanogen (Nasdaq: NGEN) announced Thursday that the US National Cancer Institute had purchased its NanoChip system for the full list price of   $150,000, but the institute’s Advanced Technology Center said the deal does not signal a preference for one technology over another.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.